By, Arti K. Rai* [PDF Version]
« BIO v. DC and the New Need to Eliminate Federal Patent Law Preemption of State and Local Price and Product Regulation | Main | Reestablishing the Doctrine of Patent Exhaustion »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c588553ef00e54f79abde8833
Listed below are links to weblogs that reference The GSK Case: An Administrative Perspective:
The comments to this entry are closed.
Comments